Onconetix, Inc. Convertible Preferred Stock, Shares Issued upon Conversion
Onconetix, Inc. (ONCO) had Convertible Preferred Stock, Shares Issued upon Conversion of 6.74 million shares as of 2024-09-30, per its 10-Q filed 2024-12-10.
Financial Statements › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures › Features of Convertible Preferred Stock
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2026-03-13
- 2024-09-30: Convertible Preferred Stock, Shares Issued upon Conversion 6.74M shares.
- 2024-06-30: Convertible Preferred Stock, Shares Issued upon Conversion 269.67M shares.
- 2024-03-31: Convertible Preferred Stock, Shares Issued upon Conversion 269.67M shares.
- 2023-12-31: Convertible Preferred Stock, Shares Issued upon Conversion 100.00 shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion | Convertible Preferred Stock, Shares Issued upon Conversion as first filed |
|---|---|---|
| 2024-09-30 | 6.74M shares 10-Q · filed 2024-12-10 | |
| 2024-06-30 | 269.67M shares 10-Q · filed 2024-08-29 | |
| 2024-03-31 | 269.67M shares 10-Q · filed 2024-05-20 | |
| 2023-12-31 | 100.00 shares 10-K · filed 2024-04-11 | |
| 2023-12-15 | 79.31K shares 10-K · filed 2026-03-13 | 6.74M shares 10-K · filed 2025-06-02 |
| 2022-12-31 | 1.15M shares 10-K · filed 2023-03-09 | |
| 2022-09-30 | 1.15M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 1.15M shares 10-Q · filed 2022-08-15 | |
| 2022-02-23 | 5.63M shares 10-K · filed 2024-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |